Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Diamedica Therapeutics Inc. (DMAC)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Diamedica Therapeutics Inc. since year 2005.
Table 2 shows the detailed insider transactions of Diamedica Therapeutics Inc. since 2005.
The reporting company's ticker symbol is DMAC. The reporting company's CIK number is 1401040.
The total value of stock buying since 2005 is $190,640.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-05-31||Pilnik Richard D. (Director)||Buy||19,000||2.80||53,200|
|2019-05-24||Kellen Scott (CFO and Secretary)||Buy||4,000||2.94||11,772|
|2019-03-27||Alcorn Harry W Jr (Chief Medical Officer)||Buy||150||4.46||668|
|2018-12-11||Xiao Zhenyu (Director)||Buy||3,250||4.00||13,000|
|2018-12-11||Pauls Dietrich John (President and CEO)||Buy||5,000||4.00||20,000|
|2018-12-11||Pilnik Richard D. (Director)||Buy||6,250||4.00||25,000|
|2018-12-11||Verdoorn Todd A. (Chief Scientific Officer)||Buy||1,000||4.00||4,000|
|2018-12-11||Parsons James T. (Director)||Buy||2,250||4.00||9,000|
|2018-12-11||Giuffre Randall Michael (Director)||Buy||11,250||4.00||45,000|
|2018-12-11||Kellen Scott (CFO and Secretary)||Buy||1,250||4.00||5,000|
|2018-12-11||Alcorn Harry W Jr (Chief Medical Officer)||Buy||1,000||4.00||4,000|
Insider trading activities including stock purchases, stock sales, and option exercises of DMAC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Diamedica Therapeutics Inc. (symbol DMAC, CIK number 1401040) see the Securities and Exchange Commission (SEC) website.